Total submissions: 8
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Genomic Research Center, |
RCV000625776 | SCV000746322 | likely benign | Amyotrophic lateral sclerosis | 2020-05-03 | criteria provided, single submitter | clinical testing | |
Suna and Inan Kirac Foundation Neurodegeneration Research Laboratory, |
RCV000022846 | SCV001251005 | uncertain significance | Amyotrophic lateral sclerosis type 15 | 2020-03-31 | criteria provided, single submitter | research | |
Illumina Laboratory Services, |
RCV000022846 | SCV001332455 | uncertain significance | Amyotrophic lateral sclerosis type 15 | 2017-04-28 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. However, the evidence from the literature, in combination with allele frequency data from public databases where available, was not sufficient to rule this variant in or out of causing disease. Therefore, this variant is classified as a variant of unknown significance. |
Invitae | RCV000022846 | SCV002408370 | benign | Amyotrophic lateral sclerosis type 15 | 2022-04-20 | criteria provided, single submitter | clinical testing | |
Gene |
RCV003441723 | SCV004168002 | uncertain significance | not provided | 2023-11-15 | criteria provided, single submitter | clinical testing | In silico analysis supports that this missense variant does not alter protein structure/function; This variant is associated with the following publications: (PMID: 26944018, 25333069, 26075709, 29161404, 27834214, 28716533, 25398946, 25616961, 26152284, 21857683, 25681989, 34426522, 35047667, 32579787, 30982635, 33891006, 33919255, 31324802, 31942019, 31167121, 32513711, 37039476, 36423739, 35936615, 31319884, 32290710, Durmus2023[Casereport]) |
Prevention |
RCV003944836 | SCV004763487 | likely benign | UBQLN2-related disorder | 2023-04-03 | criteria provided, single submitter | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |
OMIM | RCV000022846 | SCV000044135 | pathogenic | Amyotrophic lateral sclerosis type 15 | 2011-08-21 | no assertion criteria provided | literature only | |
Reproductive Health Research and Development, |
RCV000022846 | SCV001142501 | likely pathogenic | Amyotrophic lateral sclerosis type 15 | 2020-01-06 | no assertion criteria provided | curation | NM_013444.3:c.1573C>T in the UBQLN2 gene has an allele frequency of 0.007 in Ashkenazi Jewish subpopulation in the gnomAD database. The p.Pro525Ser (NM_013444.3:c.1573C>T) variant has been detected in families affected with amyotrophic lateral sclerosis (PMID: 21857683). Functional studies suggest that p.Pro525Ser exhibited intermediate solubility phenotypes compared to wild type (PMID: 29161404). Taken together, we interprete this variant as Pathogenic/Likely pathogenic. ACMG/AMP Criteria applied: PS3; PP4; PM2. |